Zurich, Switzerland

Annemarie Honegger

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 72(Granted Patents)


Location History:

  • Zurich, CH (2008)
  • Zürich, CH (2004 - 2022)

Company Filing History:


Years Active: 2004-2022

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations of Annemarie Honegger: Pioneering the Frontier of Antibody Technology

Introduction: Annemarie Honegger, an esteemed inventor based in Zurich, Switzerland, has made significant contributions to the field of biotechnology. With a remarkable portfolio of seven patents, her work primarily focuses on the development of antibodies for therapeutic and diagnostic applications. Her research addresses critical health challenges, particularly in the realm of inflammatory diseases.

Latest Patents: Among her latest innovations are two pivotal patents related to nucleic acids encoding antibodies against IL-1 beta. These inventions detail anti-IL-1 beta antibodies and, specifically, monovalent high potency IL-1 beta-binding antibody fragments that exhibit impressive stability. The implications of her work are substantial, providing therapeutic avenues for treating various inflammatory conditions and enhancing diagnostic techniques. In addition, the patents include related nucleic acids, vectors, cells, and compositions, expanding the potential applications of her research.

Career Highlights: Annemarie’s career has been marked by her tenure at prestigious institutions. Notably, she has worked with the University of Zurich, contributing to cutting-edge research in immunology. Furthermore, her collaboration with Cell Medica Limited highlights her commitment to translating scientific breakthroughs into practical medical solutions.

Collaborations: Throughout her career, Annemarie Honegger has partnered with notable experts in her field, including Andreas Plückthun and Jörg Willuda. These collaborations have enriched her research, fostering an environment of innovation and shared knowledge.

Conclusion: Annemarie Honegger stands out as a prominent figure in the field of antibody technology. Her innovative patents pave the way for advancements in treatment and diagnostics of inflammatory diseases. As she continues her work, her contributions are likely to have lasting impacts on the medical community and patient care worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…